Search research articles
Contact Us
Filters
Showing results (1-10 of 23) with videos related to
Page
of 3
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 19, 2013
Pertuzumab protects the achilles' heel of trastuzumab--emtansine
William R Gwin, Neil L Spector
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 17, 2025
TOP1 Priority: Advancing Biomarker-Driven Patient Selection for the Use of ADCs
William R Gwin, Sara A Hurvitz
Journal of Personality Assessment
|
January 1, 1997
Current status of MMPI-2 research: a methodologic overview
R L Greene, R Gwin, M Staal
Advances in Experimental Medicine and Biology
|
November 13, 2019
Immuno-Oncology in the Era of Personalized Medicine
William R Gwin, Mary L Disis, Erika Ruiz-Garcia
Targeted Oncology
|
January 29, 2021
Vaccine Therapies for Cancer: Then and Now
Michael A Morse, William R Gwin, Duane A Mitchell
Breast Cancer Research : BCR
|
July 26, 2014
A signature of epithelial-mesenchymal plasticity and stromal activation in primary tumor modulates late recurrence in breast cancer independent of disease subtype
Qing Cheng, Jeffrey T Chang, William R Gwin, et al.
Cancer Chemotherapy and Pharmacology
|
December 16, 2017
CYP1A1 genetic polymorphism is a promising predictor to improve chemotherapy effects in patients with metastatic breast cancer treated with docetaxel plus thiotepa vs. docetaxel plus capecitabine
Xinna Zhou, Guoliang Qiao, Xiaoli Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 11, 2017
<i>In Vivo</i> Detection of HSP90 Identifies Breast Cancers with Aggressive Behavior
Takuya Osada, Kensuke Kaneko, William R Gwin, et al.
American Journal of Clinical Pathology
|
March 5, 2025
Clinicopathologic and molecular characterization of low-grade, early-stage, and HER2-positive invasive breast carcinoma
Natasha Hunter, Lisa Han, Haley Corbin, et al.
Breast Cancer Research : BCR
|
February 18, 2025
Fluoroestradiol (FES) and Fluorodeoxyglucose (FDG) PET imaging in patients with ER+, HER2-positive or HER2-negative metastatic breast cancer
Natasha B Hunter, Lanell M Peterson, Jennifer M Specht, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 23) with videos related to
Sort By:
Page
of 3
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 19, 2013
Pertuzumab protects the achilles' heel of trastuzumab--emtansine
William R Gwin, Neil L Spector
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 17, 2025
TOP1 Priority: Advancing Biomarker-Driven Patient Selection for the Use of ADCs
William R Gwin, Sara A Hurvitz
Journal of Personality Assessment
|
January 1, 1997
Current status of MMPI-2 research: a methodologic overview
R L Greene, R Gwin, M Staal
Advances in Experimental Medicine and Biology
|
November 13, 2019
Immuno-Oncology in the Era of Personalized Medicine
William R Gwin, Mary L Disis, Erika Ruiz-Garcia
Targeted Oncology
|
January 29, 2021
Vaccine Therapies for Cancer: Then and Now
Michael A Morse, William R Gwin, Duane A Mitchell
Breast Cancer Research : BCR
|
July 26, 2014
A signature of epithelial-mesenchymal plasticity and stromal activation in primary tumor modulates late recurrence in breast cancer independent of disease subtype
Qing Cheng, Jeffrey T Chang, William R Gwin, et al.
Cancer Chemotherapy and Pharmacology
|
December 16, 2017
CYP1A1 genetic polymorphism is a promising predictor to improve chemotherapy effects in patients with metastatic breast cancer treated with docetaxel plus thiotepa vs. docetaxel plus capecitabine
Xinna Zhou, Guoliang Qiao, Xiaoli Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 11, 2017
<i>In Vivo</i> Detection of HSP90 Identifies Breast Cancers with Aggressive Behavior
Takuya Osada, Kensuke Kaneko, William R Gwin, et al.
American Journal of Clinical Pathology
|
March 5, 2025
Clinicopathologic and molecular characterization of low-grade, early-stage, and HER2-positive invasive breast carcinoma
Natasha Hunter, Lisa Han, Haley Corbin, et al.
Breast Cancer Research : BCR
|
February 18, 2025
Fluoroestradiol (FES) and Fluorodeoxyglucose (FDG) PET imaging in patients with ER+, HER2-positive or HER2-negative metastatic breast cancer
Natasha B Hunter, Lanell M Peterson, Jennifer M Specht, et al.
Page
of 3